Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Assets (2020 - 2025)

Historic Return on Assets for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to 0.35%.

  • Foghorn Therapeutics' Return on Assets fell 600.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.3% for FY2024, which is 200.0% down from last year.
  • Per Foghorn Therapeutics' latest filing, its Return on Assets stood at 0.35% for Q3 2025, which was down 600.0% from 0.32% recorded in Q2 2025.
  • Over the past 5 years, Foghorn Therapeutics' Return on Assets peaked at 0.21% during Q1 2022, and registered a low of 0.48% during Q3 2021.
  • Its 5-year average for Return on Assets is 0.31%, with a median of 0.3% in 2025.
  • In the last 5 years, Foghorn Therapeutics' Return on Assets surged by 2400bps in 2022 and then tumbled by -900bps in 2023.
  • Foghorn Therapeutics' Return on Assets (Quarter) stood at 0.29% in 2021, then increased by 11bps to 0.26% in 2022, then decreased by -27bps to 0.33% in 2023, then increased by 11bps to 0.29% in 2024, then fell by -19bps to 0.35% in 2025.
  • Its Return on Assets stands at 0.35% for Q3 2025, versus 0.32% for Q2 2025 and 0.3% for Q1 2025.